Advances in mass spectrometry-based technologies to direct personalized medicine in ovarian cancer
Translational Proteomics · 2013
DOI: 10.1016/j.trprot.2013.08.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Proteomics, 2013. Verfasst von Felix Leung und 3 weiteren Autor:innen. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Leung, F., Musrap, N., Diamandis, E. P., & Kulasingam, V. (2013). Advances in mass spectrometry-based technologies to direct personalized medicine in ovarian cancer. Translational Proteomics. https://doi.org/10.1016/j.trprot.2013.08.001
Vancouver
Leung F, Musrap N, Diamandis EP, Kulasingam V. Advances in mass spectrometry-based technologies to direct personalized medicine in ovarian cancer. Translational Proteomics. 2013. doi:10.1016/j.trprot.2013.08.001
BibTeX
@article{Leung2013,
author = {Leung, Felix and Musrap, Natasha and Diamandis, Eleftherios P. and Kulasingam, Vathany},
title = {Advances in mass spectrometry-based technologies to direct personalized medicine in ovarian cancer},
journal = {Translational Proteomics},
year = {2013},
doi = {10.1016/j.trprot.2013.08.001}
}
EUVIMED